Dr. Linda Ruth Silberstein

Dr. Linda Ruth Silberstein (DR. LINDA RUTH SILBERSTEIN ) is A Internal Medicine Physician in Port Chester, NY. The NPI Number for Dr. Linda Ruth Silberstein is 1528125713.

The current location address for Dr. Linda Ruth Silberstein is 430 WESTCHESTER AVE Port Chester, NY 10573 and the contact number is and fax number is . The mailing address for Dr. Linda Ruth Silberstein is 430 WESTCHESTER AVE Port Chester, NY 10573- 9149373434 (mailing address contact number - ).

A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.

What is the NPI Number for Dr. Linda Ruth Silberstein ?

Answer: The NPI Number for Dr. Linda Ruth Silberstein is 1528125713

Where is Dr. Linda Ruth Silberstein located?

Answer: Dr. Linda Ruth Silberstein is located at 430 WESTCHESTER AVE Port Chester, NY 10573.

What is the specialty for Dr. Linda Ruth Silberstein ?

Answer: The Specialty of Dr. Linda Ruth Silberstein is A Internal Medicine Physician.

Are there any online reviews for Dr. Linda Ruth Silberstein ?

Answer: Yes! Check It Now.

Are there any other health care providers in Port Chester, NY?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Internal Medicine
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	12
Number of Standardized 30-Day Fills	33
Aggregate Cost Paid for All Claims	393.09
Number of Day's Supply for All Claims	970
Number of Medicare Beneficiaries
Number of Claims, Including Refills, for Beneficiaries Age 65+	12
Including Refills, for Beneficiaries Age 65+	33
Beneficiaries Age 65+	393.09
Number of Day's Supply for All Claims for Beneficaries Age 65+	970
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst	*
Total Claims of Brand-Name Drugs
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst	*
Total Claims of Generic Drugs, Including Refills
Aggregate Cost Paid for Generic Drugs
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	0
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	0
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	12
Aggregate Cost Paid for Claims Filled by	393.09
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst	*
Number of Claims for Beneficiaries Covered by Low-Income Subsidy
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst	*
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy
by Low-Income Subsidy
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including
Aggregate Cost Paid for Antibiotic Drugs
Antibiotic Claims
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	0
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	0
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	79.875
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American
Number of Asian Pacific Islander
Number of Hispanic Beneficiaries
Number of American Indian/Alaskan NativeBeneficiaries
Number of Beneficiaries with Race Not
Only Entitlement
Average Hierarchical Condition Category	0.7245